Jasper Therapeutics Inc.-CW26JSPRWPreferred / convertible
13F holders, Q3 2025 (September 30)8holders +2
2new positions
1sold out
$0.32avg. 13F price*
At the end of Q3 2025, 8 institutions reported holding Jasper Therapeutics Inc.-CW26 (JSPRW) in their 13F filings, up 2 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were Boothbay Fund Management, LLC ($851K), Toronto Dominion Bank ($173K) and Walleye Capital LLC ($45K).
- Company
- Jasper Therapeutics Inc.-CW26
- CUSIP
- 471871111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $851K |
| Exits | 1 | $6K |
All 13F filers, Q2 2025 → Q3 2025: 357,548 shares bought and 67,959 shares sold, net +289,589 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Boothbay Fund Management, LLC | — | New | 357,447 | $851K |
| Toronto Dominion Bank | — | Reduce -0.1% | 2,167,769 | $173K |
| Walleye Capital LLC | — | No change | 560,061 | $45K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 250,000 | $20K |
| Walleye Trading LLC | — | No change | 34,142 | $3K |
| Clear Street Group Inc. | — | — | 120 | $10 |
| Bank of America Corp. | — | New | 101 | $8 |
| IFP Advisors, Inc | — | No change | 50 | $4 |
"% of holder's portfolio" is JSPRW's weight in each manager's 13F, not the share of Jasper Therapeutics Inc.-CW26 the manager owns.